Protective association of TNFSF15 polymorphisms with Crohn's disease and ulcerative colitis: A meta-analysis

• Main Authors: Liwen He, Jiamin Chen, Jiachen Sun, Junsheng Peng, Qing He
• Format: Article
• Language: English
• Published: Wolters Kluwer Medknow Publications 2018-01-01
• Series: The Saudi Journal of Gastroenterology
• Subjects: Inflammatory bowel diseases; meta-analysis; polymorphism; TNFSF15
• Online Access: http://www.saudijgastro.com/article.asp?issn=1319-3767;year=2018;volume=24;issue=4;spage=201;epage=210;aulast=He
• ISSN: 1319-3767; 1998-4049

Background/Aims: Three extensively investigated polymorphisms (rs3810936, rs7848647, and rs6478108) in tumor necrosis factor super family member 15 (TNFSF15) gene have been implicated in risk for inflammatory bowel disease (IBD). We performed a quantitative synthesis of the evidence to clarify these associations of TNFSF15 polymorphisms with IBD. Materials and Methods: Data were extracted from PubMed and EMBASE, up to March 15, 2018. Meta-analysis was performed by critically reviewing five studies for rs3810936 polymorphism (2251 cases and 2442 controls), four studies for rs7848647 polymorphism (1503 cases and 1816 controls), and four studies for rs6478108 polymorphism (1502 cases and 1817 controls). Results: Our analysis suggested that rs3810936 polymorphism was significantly associated with decreased risk of Crohn's disease (CD) and ulcerative colitis (UC). For rs7848647 polymorphism, significantly protective association between this polymorphism and CD risk was also observed, but not in UC. For rs6478108 polymorphism, we also detected a significantly protective association with CD risk in all genetic model but not in UC. Conclusions: This meta-analysis suggests that TNFSF15 polymorphisms may contribute to genetic susceptibility of IBD.